Abstract: GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving a -GBV-C NS5A peptide or polypeptide for inhibiting and treating HIV infections.
Type:
Grant
Filed:
March 20, 2008
Date of Patent:
September 18, 2012
Assignee:
University of Iowa Research Foundation
Inventors:
James McLinden, Jinhua Xiang, Jack T. Stapleton